Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group Phase 4 Study of the Efficacy & Safety of Patiromer for Oral Suspension in Combination With Standard of Care Treatment in ED Patients With Hyperkalemia

NCT04443608 is registered in ClinicalTrials.gov with Comprehensive Research Associates as lead sponsor.

NCT NCT04443608
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04443608 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group Phase 4 Study of the Efficacy & Safety of Patiromer for Oral Suspension in Combination With Standard of Care Treatment in ED Patients With Hyperkalemia
Lead sponsor
Comprehensive Research Associates
Phase
Phase 4
Overall status
Terminated
Start date
October 8, 2020
Completion date
June 3, 2023
Enrollment
115 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

hyperkalemia